Clinical Trials Logo

Noncommunicable Diseases clinical trials

View clinical trials related to Noncommunicable Diseases.

Filter by:

NCT ID: NCT05005130 Completed - HIV Clinical Trials

Task-shifted Adaptation of the WHO-PEN Intervention to Address Cardio-metabolic Complications in People Living With HIV in Zambia

TASKPEN
Start date: September 20, 2021
Phase: N/A
Study type: Interventional

This mixed-methods formative research study aims to adapt the WHO Package of Essential Noncommunicable Disease Interventions (WHO-PEN) approach for the Zambian public health system, and pilot test an adapted, streamlined, and task-shifted package of integrated HIV Noncommunicable Disease (NCD) services, collectively called "TASKPEN".

NCT ID: NCT04961073 Completed - Clinical trials for Non-communicable Diseases

Prevalence of Multiple Risk Behaviours and Its Association With Health Consequence

Start date: June 21, 2021
Phase:
Study type: Observational

Hong Kong is facing an increasing threat of non-communicable diseases (NCDs), which is compounded by population aging. In 2016, 25,771 registered deaths (approximately 55%) were attributed to NCDs. In addition, NCDs caused 104,600 potential years of life lost before 70 years of age. WHO has identified four major behavioral risk factors - tobacco use, harmful use of alcohol, an unhealthy diet, and physical inactivity - that contribute substantially to NCDs and can increase the risk of death. Most premature deaths from NCDs are preventable via lifestyle modification. Therefore, helping people adopting healthy lifestyle practices, such as having a balanced diet and engaging in irregular physical activity, and quitting health-risk behaviors, such as smoking and harmful use of alcohol can help prevent NCDs and improve the quality of life and overall health of the population. However, many people are unmotivated or find it difficult to modify their risk behaviors, despite their awareness of the associated health hazards.

NCT ID: NCT04947787 Recruiting - Clinical trials for Non-Communicable Chronic Diseases

Establishing a Physical Activity Referral Scheme for People With Noncommunicable Diseases in the German Healthcare System

BewegtVersorgt
Start date: February 1, 2022
Phase: N/A
Study type: Interventional

The BewegtVersorgt project involved co-producing a physical activity referral scheme (PARS) for inactive persons with underlying non-communicable diseases. Various relevant actors of the German healthcare system (e.g., representatives of physicians, health insurance providers, sports organizations, exercise representatives of exercise professions, representatives of patients) participated in the co-production process. The purpose of this study is to evaluate the effectiveness of co-produced PARS in the Erlangen-Nuremberg-Fürth region. Local general practitioners and exercise professionals will carry out the implementation of the PARS in standard care. The cluster-randomized study includes two intervention arms; one group will receive specific support from physical activity experts to increase physical activity (PARS). The control group will receive only the physician's advice and then continue to engage in physical activity on their own (PAA). The participants will be followed up at 12 and 24 weeks.

NCT ID: NCT04827615 Active, not recruiting - Blood Pressure Clinical Trials

Evaluation of the Ambuja Cement Foundation Noncommunicable Disease Program in Bathinda District of Punjab, India

Start date: July 30, 2019
Phase: N/A
Study type: Interventional

This is an academic evaluation of a program being implemented by the Ambuja Cement Foundation (ACF). The aim of the evaluation is to determine the effect of the ACF noncommunicable disease (NCD) program on (1) fasting blood glucose (a biomarker of diabetes), (2) systolic blood pressure, (3) diastolic blood pressure, and (4) body weight. ACF will be implementing a program on NCD management. Due to resource constraints, the program will be implemented stepwise (e.g. four villages in the first 6 months then an additional four villages added every 6 months over the next 12 months). In order to improve the interpretation of the evaluation data, the team will randomize the order in which the program is implemented in the 12 villages. The design is therefore a stepped wedge randomized cluster trial. This design is ideal for (1) minimizing the practical, logistical, and financial constraints associated with large-scale project implementation, (2) control for the effect of time, and (3) ensure that all villages in the project are eventually offered the intervention.

NCT ID: NCT04820556 Completed - Asthma Clinical Trials

Gut Microbiota in Chronic Noncommunicable Diseases

Start date: April 12, 2021
Phase:
Study type: Observational

It is an observational study in patients with chronic noncommunicable diseases (i.e. cardiovascular diseases, diabetes mellitus, non-alcoholic fatty liver disease, chronic obstructive pulmonary disease and asthma ) and control group with no signs of these conditions. The study has a prospective part planned for 2021 and a retrospective part which includes the patients enrolled between 2018-2020. The aim of the study is to investigate gut microbiota composition, its metabolites, levels of inflammatory and other markers of the disease in prospective groups (arterial hypertension, type 2 diabetes mellitus, chronic obstructive pulmonary disease, asthma, non-alcoholic fatty liver disease and control patients) as well as in retrospective groups (chronic heart failure with preserved and reduced ejection fraction, obstructive atherosclerosis of any vascular bed, arterial hypertension, type 2 diabetes mellitus, chronic obstructive pulmonary disease, asthma, non-alcoholic fatty liver disease, and control patients). Also we are planning to investigate the association between gut microbiota composition and its metabolites, levels of inflammatory and other markers of the disease in retrospective and prospective groups.

NCT ID: NCT04645693 Recruiting - HIV Clinical Trials

The Impact of Oral Health in HIV Patients on Antiretroviral Therapy

OHART
Start date: February 24, 2021
Phase:
Study type: Observational [Patient Registry]

This is a prospective cohort study designed to investigate the range of metabolic abnormalities observed in patients living with HIV on antiretroviral therapy. This study will also explore the concurrent role of poor oral health in supporting and driving chronic immune activation and inflammation in HIV infection.

NCT ID: NCT04600726 Not yet recruiting - Clinical trials for Older Adults With Mild Neurocognitive Disorders

Application of VR-based Working Memory Screening Test

VR
Start date: February 1, 2021
Phase:
Study type: Observational [Patient Registry]

We propose to validate an interactive, immersive spatial memory test from the laboratory test. This VR-based working memory test (VRWMT) is a first-person, self-pacing game embedded within a virtual reality environment, the program is easily implemented with minimal instructions and no supervision that can be community-users friendly. It is specifically designed to assess rapid spatial working memory - a common deficit in all NCD subtypes. Its ability to detect pathological models of dementia, age-related deterioration, and hippocampal dysfunction are well established in literature

NCT ID: NCT04567121 Recruiting - Clinical trials for Non Communicable Diseases

Internet Technology Based Life-style and Care Intervention for Risk Factors of Non Communicable Diseases(NCD)

Start date: January 1, 2018
Phase: N/A
Study type: Interventional

This study aims to control risk factors of non communicable diseases by life style and care intervention based on internet technology, looking forward to improve cardiovascular and cerebrovascular complications, diabetes and all-cause death.

NCT ID: NCT04513236 Completed - Clinical trials for Surveys and Questionnaires

Use of Airtime Timing to Improve Interactive Voice Response Surveys in Bangladesh and Uganda

Start date: March 26, 2017
Phase: N/A
Study type: Interventional

This study evaluates the effect of two different airtime incentive timings on interactive voice response (IVR) survey cooperation, response, refusal and contact rates, as compared to a control group, in Bangladesh and Uganda.

NCT ID: NCT04508010 Completed - Clinical trials for Surveys and Questionnaires

Comparison of IVR and CATI Surveys in Bangladesh

Start date: August 25, 2020
Phase: N/A
Study type: Interventional

This study focuses on mechanisms to adapt the performance of interactive voice response (IVR) and computer assisted telephone interviews (CATI) surveys conducted in low-and middle-income (LMIC) setting (Bangladesh) and evaluates how the two survey modalities (IVR and CATI) affect survey metrics, including response, completion and attrition rates.